Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.50 |
| ▸ | RAB9A | P51151 | 8/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.50 |
| ▸ | HPGD | P15428 | 7/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.43 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | IGF2BP2 | Q9Y6M1 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4649274 | 0.85 | NPC1 (0.47) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL11541708 | 0.83 | NPC1 (0.46) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL11542384 | 0.82 | NPC1 (0.45) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| Octrizole SCHEMBL5072028 | 0.81 | NPC1 (0.46) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| Benzene SCHEMBL9190034 | 0.80 | NPC1 (0.41) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL11540965 | 0.80 | NPC1 (0.43) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL285733 | 0.79 | NPC1 (0.78) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL29575333 | 0.79 | NPC1 (0.78) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL28065049 | 0.77 | NPC1 (0.54) | NPC1RAB9AALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL226072 | 0.77 | IDH1 (0.35) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036555-A1 | Stabilization of iodine biocides | LANXESS DEUTSCHLAND GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1926367-A1 | STABILIZATION OF IODINE BIOCIDES | Lanxess Deutschland GmbH & Co.KG (DE) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007028527-A1 | STABILIZATION OF IODINE BIOCIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036555-A1 | Stabilization of iodine biocides | LCT, BTD, HDHD5 | NPC1 4023/4885RAB9A 2647/4885ALDH1A1 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.